Natural Procreative Technology, (also called  NaProTECHNOLOGY®, NaPro, or NPT)  is a new reproductive science that works cooperatively with the natural fertility [menstrual] cycle. It has been developed as a series of medical applications based on a standardized assessment of the biomarkers of the fertility [menstrual] cycle, known as the Creighton Model FertilityCare System. It can be used to evaluate and treat infertility, miscarriage, irregular bleeding, and many other women’s health conditions.

The Creighton Model FertilityCare™ System teaches couples to recognize, understand, and record the changes that occur during the fertility [menstrual] cycle. These changes [biomarkers] indicate whether the reproductive system is functioning normally or not. It also identifies ovulation and other key events. It is completely natural and cooperative with a woman’s fertility [menstrual] cycle. 

NPT is proving to be highly effective in treating couples with infertility. Couples use the Creighton Model FertilityCare System to identify abnormalities in their fertility [menstrual] cycle even before trying to conceive. Clinical signs [biomarkers] such as 3 or more days of brown menstrual bleeding, reduced quality and quantity of cervical mucus flow, premenstrual spotting, or abnormal lengths of time after ovulation, suggest possible causes for infertility. Many of these signs are missed with current gynaecologic evaluation. Hormonal evaluation guided by the couple’s charting allows the NPT-trained physician to identify and treat subtle hormonal deficiencies that may otherwise be undetected. The goal with NaProTECHNOLOGY fertility treatment is to recognize reproductive abnormalities and correct them. Surgical intervention may be recommended to compliment medical treatment when necessary.

Considering all patient ages and diagnoses, the overall probability of having a successful pregnancy with NaProTECHNOLOGY is approximately 50%. The success rate can be up to 80% depending on multiple factors including the precise diagnosis, severity of the underlying cause, history of previous fertility treatment and female age. NaProTECHNOLOGY is not an option in cases of established menopause, zero sperm count or persistent bilateral blocked fallopian tubes (despite attempted surgical reconstruction). A couple will be told what their chances of success are during the initial medical consultation and it is up to them to decide if they would like to commence further evaluation and treatment. Nearly every category of infertility has succeeded with this approach including Unexplained Infertility, Endometriosis, Polycystic Ovarian Disease, Pelvic Adhesions, Low Progesterone, Hostile Mucus, Male or Female antibodies, Low sperm count, Oligo-ovulation and Anovulation. Even couples who have previously failed In Vitro Fertilisation (IVF) or Intra-Cytoplasmic Sperm Injection (ICSI) have a reasonable chance of a live birth with NPT. Although there is real hope with NaProTECHNOLOGY , not all couples will conceive. All couples undergoing NPT evaluation obtain a greater understanding of what is happening with their bodies and how they can maximize their chances of healthy pregnancy.

Yes. If the primary diagnosis is a male factor, couples have had successful pregnancies using NaProTECHNOLOGY. Men with very low sperm counts or anti-sperm antibodies can be treated. Often, improvements in semen quality can be made by healthy lifestyle changes. A number of medical and surgical treatments can also improve semen quality and sperm function. Even if the sperm function is not ideal, evaluating and maximizing the woman’s fertility cycle, together with ideal timing of intercourse will often result in pregnancy. The overall success rate for male factor infertility is around 40%.

There is a fundamental difference in approach. NPT identifies what is not working and fixes it, so that conception and pregnancy can occur naturally in vivo [in the body]. ART and related approaches bypass the problem and make a baby in vitro [outside the body]. Many of the issues (cost, side effects, ethical concerns) raised by ART are not a problem with NPT.

No. NPT supports and optimises natural reproductive function, so that pregnancy can result from natural sexual intercourse.

NPT identifies miscarriage as an abnormality rather than a common normal reproductive event. Furthermore it recognises that there are underlying causes to each miscarriage, even though the causes may not always be identifiable. NPT fully evaluates the possible causes of even one miscarriage and in fact prefers to identify and correct abnormalities before any miscarriage occurs.

Clinical signs [biomarkers] from the couple’s fertility chart suggest possible reasons for miscarriage. Hormonal evaluation guided by the couple’s charting allows the NPT-trained physician to identify and treat hormonal deficiencies to reduce the risk of even one miscarriage occurring, or in the case of women who have suffered recurrent miscarriages, reducing the risk of another miscarriage.

Yes. The woman’s charting of her clinical signs [biomarkers] of the fertility cycle (menstrual cycle), gives great insight into menstrual cycle disorders. The underlying causes of many of these problems can be the same. Hormonal evaluation guided by the charting allows the NPT-trained physician to identify abnormalities in the menstrual cycle and correct them. This can improve or resolve the problem.

Problems that can be helped with NaProTECHNOLOGY include

• Infertility
• Miscarriage
• Premature Birth
• Ovarian Cysts
• Premenstrual Syndrome
• Postpartum Depression
• Irregular Cycles
• Premenopausal Symptoms
• Irregular Vaginal Bleeding
• Family Planning